Imunon

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Imunon and other ETFs, options, and stocks.

About IMNN

Imunon, Inc. is a clinical stage oncology drug company. It focuses on cancer treatments, including directed chemotherapies, DNA-mediated immunotherapy and RNA-based therapies. 

CEO
Stacy R. Lindborg
CEOStacy R. Lindborg
Employees
25
Employees25
Headquarters
Lawrenceville, New Jersey
HeadquartersLawrenceville, New Jersey
Founded
1982
Founded1982
Employees
25
Employees25

IMNN Key Statistics

Market cap
18.23M
Market cap18.23M
Price-Earnings ratio
-0.19
Price-Earnings ratio-0.19
Dividend yield
—
Dividend yield—
Average volume
416.57K
Average volume416.57K
High today
$9.49
High today$9.49
Low today
$8.23
Low today$8.23
Open price
$8.70
Open price$8.70
Volume
133.44K
Volume133.44K
52 Week high
$47.40
52 Week high$47.40
52 Week low
$5.55
52 Week low$5.55

People also own

Based on the portfolios of people who own IMNN. This list is generated using Robinhood data, and it’s not a recommendation.
SNDL
Lucid Group
Ocugen, Inc
NIO
Castor Maritime
Cenntro Inc.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.